Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
About Index
Index
By TNW
Log in
Register
SteadyMed Therapeutics
1518
SteadyMed Therapeutics
Health Care
Medical
Pharmaceuticals
SteadyMed aspires to redefine the parenteral therapeutics experience for patients dependent upon large doses of intravenous and subcutaneous medications.
Suggest edits
Type
B2c
Founded
2005
Raised
$77.4M
Follow us
Companies in the same industry
GC-Rise Pharmaceutical
Ark Biosciences
JD Health
Metis Precision Medicine
Taro Pharmaceuticals
DailyRounds
Esperion Therapeutics
Amplyx Pharmaceuticals, Inc
VG Life Sciences
Spinal Simplicity
Alexa global traffic share
Twitter followers
Overview
Funding
6
Add info
Latest funding
Show all
$30,000,000
Post-IPO equity - 2017
Adage Capital Management
OrbiMed
Deerfield Capital Management
+3
$32,000,000
Post-IPO equity - 2016
OrbiMed
Deerfield Capital Management
Federated Investors
Team Size
10+
Employees
I work here
Location
Israel
Headquarters
Explore Israel
$30,000,000
Post-IPO equity
Drug Delivery Business
,
NoCamels - Israeli Tech and Innovation News
SteadyMed raises $30m for Trevyent commercial launch
